Outlook Therapeutics Inc (Outlook Therapeutics Inc (OTLK)) is higher by Monday morning, with the stock increasing 8.26% in pre-market trading to 2.36.
OTLK's short-term technical score of 98 indicates that the stock has traded more bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 83 out of 146 industries, Outlook Therapeutics Inc ranks higher than 99% of stocks.
Outlook Therapeutics Inc has risen 70.31% over the past month, closing at $1.26 on January 11. During this period of time, the stock fell as low as $0.94 and as high as $2.55. OTLK has an average analyst recommendation of Strong Buy. The company has an average price target of $5.00.
Outlook Therapeutics Inc has a Long-Term Technical rank of 95. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 5% of the market scoring higher. In the Biotechnology industry which is number 65 by this metric, OTLK ranks better than 90% of stocks.
Important Dates for Investors in OTLK:
-Outlook Therapeutics Inc is set to release earnings on 2/12/2021. During their last earnings release the company posted EPS of $-0.99. -We do not have a set dividend date for Outlook Therapeutics Inc at this time. Click Here to get the full Stock Score Report on Outlook Therapeutics Inc (OTLK) Stock.